Haloperidol as an antiemetic following abdominal hysterectomy - a comparison with Zofran®

ISRCTN ISRCTN21871435
DOI https://doi.org/10.1186/ISRCTN21871435
Protocol serial number N0558111116
Sponsor Department of Health (UK)
Funder Milton Keynes General NHS Trust (UK)
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
17/09/2012
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Andrew White
Scientific

Milton Keynes General NHS Trust
Standing Way
Eaglestone
Milton Keynes
MK6 5LD
United Kingdom

Phone +44 (0)1908 660033
Email andrew.white@mkgeneral.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesFollowing withdrawal of Droperidol can Haloperidol, which has been used in palliative care, give good antiemetic effect following acute surgery?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPost operative antiemetics
InterventionProspective randomised trial.

17/09/2012: Please note that this trial was stopped as the trial objectives were no longer viable
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Haloperidol, ondansetron (Zofran®)
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/09/2003
Reason abandoned (if study stopped)Objectives no longer viable

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Key inclusion criteriaAll American Society of Anesthesiologists (ASA) I - III females undergoing abdominal hysterectomy who give their consent.
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/10/2001
Date of final enrolment30/09/2003

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Milton Keynes General NHS Trust
Milton Keynes
MK6 5LD
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan